Aublé advises the founders of Epigene Labs on its new round of financing from the European Innovation Council Fund and its historical investors.

Advised by Matthieu Aublé, biotech Epigene Labs has secured strategic financing from the EIC IMPACT TRUST - EIC IMPACT FUND - Eastern Investment Centers. The start-up also benefits from the renewed confidence of its historical investors, such as the daphni fund, XAnge (Siparex Group), and Majycc Innovation Santé - UI Investissement. 

This investment marks the exceptional technological and scientific progress made by Epigene Labs, which also received a multi-million euro grant last year as part of the EIC Accelerator program.